Related Experiment Video
Updated: Jun 23, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells
Tomoaki Tanaka1, Hidenori Kawashima, Keiko Ohnishi
1Department of Urology, Osaka City University, Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Japan. tomoaki826@msic.med.osaka-cu.ac.jp
Abstract:
Bisphosphonates are strong inhibitors of osteoclastic bone resorption in both benign and malignant bone diseases. The nitrogen-containing bisphosphonates (N-BPs) have strong cytotoxicity via inhibition of protein prenylation in the mevalonate pathway, and also demonstrate direct cytostatic and proapoptotic effects on prostate cancer cells. We confirmed the usefulness of a co-culture system comprised of prostatic LNCaP cells, ST2 cells (mouse-derived osteoblasts) and MLC-6 cells (mouse-derived osteoclasts) in vitro. N-BPs (pamidronate and zoledronic acid) inhibited both androgen receptor transactivation and tumor cell proliferation by suppressing the activities of both osteoclasts and osteoblasts with low-dose exposure. This indirect inhibition of prostate cancer cells via bone cells could be beneficial in treating prostate cancer patients with bone metastases.
Insights
Nitrogen-containing bisphosphonates (N-BPs) show promise in treating prostate cancer with bone metastases. These drugs inhibit bone resorption and tumor cell proliferation by affecting bone cells, offering a novel therapeutic strategy.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Bisphosphonates inhibit osteoclastic bone resorption, crucial in bone diseases.
- Nitrogen-containing bisphosphonates (N-BPs) exhibit cytotoxicity and anti-cancer effects on prostate cancer cells.
- N-BPs target the mevalonate pathway, inhibiting protein prenylation.
Purpose of the Study:
- To evaluate the efficacy of N-BPs in a co-culture system of prostate cancer cells and bone cells.
- To investigate the indirect effects of N-BPs on prostate cancer cell proliferation and androgen receptor activity.
- To explore the potential of N-BPs in treating prostate cancer with bone metastases.
Main Methods:
- Utilized a co-culture system with LNCaP (prostate cancer), ST2 (osteoblasts), and MLC-6 (osteoclasts) cells.
- Administered low doses of N-BPs (pamidronate, zoledronic acid).
- Assessed inhibition of androgen receptor transactivation and tumor cell proliferation.
Main Results:
- N-BPs suppressed the activity of both osteoblasts and osteoclasts in the co-culture system.
- Low-dose N-BP exposure inhibited prostate cancer cell proliferation.
- Androgen receptor transactivation in prostate cancer cells was also inhibited by N-BPs.
Conclusions:
- N-BPs can indirectly inhibit prostate cancer cells by modulating the activity of surrounding bone cells.
- This indirect mechanism presents a potential therapeutic approach for prostate cancer patients with bone metastases.
- The co-culture system proved useful for studying N-BP effects in a bone microenvironment context.

